David Thomson
General Counsel at MANNKIND CORPORATION
Net worth: 4 M $ as of 2024-04-29
David Thomson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MANNKIND CORPORATION | General Counsel | 2001-12-31 | - |
| Corporate Secretary | 2001-12-31 | - | |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - | - |
Career history of David Thomson
Training of David Thomson
| Queen's University | Doctorate Degree |
| University of Toronto | Graduate Degree |
Statistics
International
| United States | 3 |
| Canada | 3 |
Operational
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Secretary | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
- Stock Market
- Insiders
- David Thomson
- Experience
